HEALTHCARE GLOBAL ENTERPRISES LTD.
NSE : HCGBSE : 539787ISIN
CODE : INE075I01017Industry : Hospital & Healthcare ServicesHouse
: HCG
BSE369.5015.1 (+4.26 % )
PREV CLOSE (Rs.) 354.40
OPEN PRICE (Rs.) 365.45
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 26393
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE369.35 13.4 (+3.76 % )
PREV CLOSE(Rs.) 355.95
OPEN PRICE (Rs.) 368.00
BID PRICE (QTY) 369.35 (81 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 923292
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 09-Mar-2024 | HealthCare Global Enterprises informs about Acquisition | <p style="text-align: justify;">HealthCare Global Enterprises informed about the execution of Transfer of Partnership Interest Agreement (TPIA) for the acquisition of minority interest in HCG EKO Oncology LLP (HCG EKO LLP).</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE. </p><div><br></div> |
| 26-Feb-2024 | HealthCare Global Enterprises submits analyst meet intimation | <div style="text-align: justify;">Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, HealthCare Global Enterprises has informed that the officials of the Company will be meeting Investors/ Analysts (Participants) on February 28, 2024 as per the details enclosed.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 30-Dec-2023 | HealthCare Global Enterprises informs about newspaper publication | <div style="text-align: justify;">HealthCare Global Enterprises has attached copies of newspaper advertisement published in Business Standard (English) and Vijayawani (Kannada) on December 30, 2023 with regard to postal ballot notice dated December 29, 2023.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 18-Nov-2023 | HealthCare Global Enterprises informs about earnings call transcript | <div style="text-align: justify;">HealthCare Global Enterprises has informed that it enclosed Transcript of the earnings call held on November 10, 2023 with analysts/investors to discuss on the unaudited financial results for the quarter and half year ended Sept 30, 2023.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;"><br></div> |
| 05-Oct-2023 | Nazara Technologies, Strides Pharma Science and TCPL Packaging to see some action today | <p style="text-align: justify;"><b>Nazara Technologies</b>' material subsidiary -- Nodwin Gaming's Singapore subsidiary has acquired a 100% stake in game marketing agency PublishME for a sum of $2 million from its existing shareholders Nazara Technologies and Ozgur Ozalp. The integration and acquisition of PublishME into NODWIN Gaming's global emerging market network are poised to enhance NODWIN Gaming's existing solutions capabilities for publishers and brands alike. This acquisition will provide the essential tailwinds for NODWIN Gaming to drive its mission of leading the emerging market sports media landscape.</p><p style="text-align: justify;"><b>Strides Pharma Science</b>'s step-down wholly owned subsidiary -- Strides Pharma Global has received approval for Efavirenz (600mg), Emtricitabine (200mg), Tenofovir Disproxil Fumurate (300mg) (EET) tablets from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Atripla Tablets of Gilead Sciences LLC. The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products.</p><p style="text-align: justify;"><b>TCPL Packaging</b> has further acquired 38600 shares of its subsidiary company namely Creative Offset Printers (COPPL) from one of the promoters of COPPL at a consideration of Rs 1.85 crore. Post-acquisition / transfer of shares as aforesaid, the company holds 94.67% of the share capital of COPPL.</p><p style="text-align: justify;"><b>HealthCare Global Enterprises</b> has completed the acquisition of SRJ Health Care's comprehensive cancer care center in Indore, Madhya Pradesh on a slump sale basis and Amrish Oncology Services' Radiation business in Indore, Madhya Pradesh on a slump sale basis (collectively known as Business Undertaking) on October 04, 2023. Accordingly, the Business Undertaking would operate as a business unit of the Company, effective from October 04, 2023. </p><p style="text-align: justify;">Marine Electricals (India) has received order amounting to Rs 2.28 crore (excluding taxes) from <b>Cochin Shipyard</b>, Kochi for supply and services of Addressable Food Alarm System (AFAS) for ASW SWC. The delivery period shall be over a period of 2 years.</p><p style="text-align: justify;"><b>Samvardhana Motherson International</b> has raised Rs 1500 crore through allotment of 1,50,000 Rated, Listed, Unsecured, Redeemable, Non-Convertible Debentures (NCDs) having face value of Rs 1,00,000 each on private placement basis on October 4, 2023. The said NCDs will be listed on the Wholesale Debt Market segment of BSE. </p><p style="text-align: justify;"><b>Exide Industries</b> has invested Rs 340 crore by the way of subscription in the equity share capital of Exide Energy Solutions (EESL), a wholly owned subsidiary on right basis. EESL is in the process of setting up a plant for manufacturing & selling lithium-ion battery cells, modules and pack business. The company has made further investment by subscribing to equity shares offered by EESL on a rights basis to fund its green field project and meet various funding requirements. With the current investment, EIL shareholding in EESL remains unchanged at 100%.</p> |
| 04-Oct-2023 | HealthCare Global Enterprises completes acquisition of Oncology & Radiation business | <p style="text-align: justify;">HealthCare Global Enterprises has completed the acquisition of SRJ Health Care's comprehensive cancer care center in Indore, Madhya Pradesh on a slump sale basis and Amrish Oncology Services' Radiation business in Indore, Madhya Pradesh on a slump sale basis (collectively known as Business Undertaking) on October 04, 2023. Accordingly, the Business Undertaking would operate as a business unit of the Company, effective from October 04, 2023. </p><p style="text-align: justify;">HealthCare Global Enterprises (HCG) is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann' brand.</p><div style="text-align: justify;"><br></div> |
| 04-Oct-2023 | HealthCare Global Enterprises informs about disclosure | <div>Further to the intimation made to the stock exchanges on August 10, 2023, with regard to the execution of the following agreements by the Company: Business Transfer Agreement with SRJ Health Care, including their promoters, for the acquisition of their comprehensive cancer care centre in Indore, Madhya Pradesh on a slump sale basis; Business Transfer Agreement with Amrish Oncology Services, including their promoters, for the acquisition of their Radiation business in Indore, Madhya Pradesh on a slump sale basis, HealthCare Global Enterprises has informed that the Company has completed the acquisition of the Business Undertaking, as contemplated in the Business Transfer Agreements as mentioned above, on October 04, 2023. Accordingly, the Business Undertaking would operate as a business unit of the Company, effective from October 04, 2023.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 11-Aug-2023 | HealthCare Global Enterprises executes BTA with SRJ Health Care, AOSPL | <p style="text-align: justify;">HealthCare Global Enterprises (HCG) has executed Business Transfer agreements (BTA) on August 10, 2023, with SRJ Health Care, and Amrish Oncology Services (AOSPL), including their promoters, for the acquisition of their Oncology business and Radiation business, respectively, on a slump sale basis, in Indore, Madhya Pradesh (collectively known as Business Undertaking).</p><p style="text-align: justify;">This acquisition would enable HCG to enter into a new market – Indore. SRJ has strong surgical and medical oncology practice in Indore which is ably supplemented by AOSPL with its radiation oncology service. HCG proposes to further expand its operations in Indore, and in this regard has agreed to take over the upcoming oncology facility of SRJ in Indore, on a lease basis, which is expected to commence its operations in 2 years. </p><p style="text-align: justify;">HealthCare Global Enterprises (HCG) is Bangalore based provider of speciality healthcare in India focused on cancer and fertility. It operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. It also operates fertility centres under the ‘Milann' brand.</p> |
| 11-Aug-2023 | HealthCare Global Enterprises informs about press release | <div style="text-align: justify;">HealthCare Global Enterprises has informed that it attached copies of newspaper advertisement published in Business Standard (English) and Vijayawani (Kannada) on August 11, 2023 with regard to approval of unaudited financial results for the quarter ended June 30, 2023 at the meeting of Board of Directors held on August 10, 2023.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 28-Jul-2023 | HealthCare Global Enterprises informs about conference call | <p style="text-align: justify;">With respect to the meeting of the Board of Directors of the Company, to be held on Thursday, August 10, 2023, to consider, approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter ended June 30, 2023 (‘Unaudited Financial Results'), HealthCare Global Enterprises has informed that, an Earnings Conference Call has been scheduled on Friday, August 11, 2023, at 10.00 am (IST), to discuss the Unaudited Financial Results of the Company. The details of the Earnings Call are attached.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p><div style="text-align: justify;"><br></div> |
